Company Profile
Achieve Life Sciences Stock Price, News & Analysis
- Ticker:
- ACHV
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Achieve Life Sciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
5.01 USD (-1.76%)
Close
Last updated: June 23, 2026 at 00:00
514.32M USD
Market cap
Why the stock is moving
ACHV is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Achieve Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Achieve Life Sciences is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Achieve Life Sciences follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Achieve Life Sciences sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
Source: Achieve Life Sciences
- 02
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
Source: Achieve Life Sciences
- 03
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
Source: Achieve Life Sciences
- 04
- 05
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
Source: Achieve Life Sciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Achieve Life Sciences (ACHV)?
Achieve Life Sciences (ACHV) most recently closed at 5.01 USD, a -1.76% move versus the previous session.
What is the market cap of Achieve Life Sciences (ACHV)?
Achieve Life Sciences currently has a market capitalization of 514.32M USD on BioPharmSignal.
What does Achieve Life Sciences do?
Achieve Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ACHV stock listed?
Achieve Life Sciences (ACHV) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Achieve Life Sciences is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Achieve?
Achieve Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Achieve Life Sciences targeting with Achieve?
Achieve Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Life?
Achieve Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Sciences?
Achieve Life Sciences is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.